Komori
Teac (6803) · FactUpdated the full-year amount

¥905 Million Spent on R&D

First written in FY2017-Q3. . Latest entry: FY2026.

32entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q3 – FY20262017: 420172018: 420182019: 320192020: 420202021: 420212022: 420222023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 73 companies write about · 0 as a headwind · 21 as a tailwind

49 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2026Updated the full-year amountAnnual report

    「The number of development personnel in the fiscal year was 92, and ¥1,244 million was spent on research and development.」

    Disclosed 92 development personnel and ¥1,244 million in R&D expenses for FY2026.
  2. FY2026-H1Updated the half-year amountAnnual report

    「The total research and development expenses incurred by the Group during the interim consolidated accounting period were ¥619 million.」

    Disclosed total R&D expenses of ¥619 million for FY2026-H1.
  3. FY2025-H1Updated the half-year amountAnnual report

    「The total research and development expenses incurred by the Group during the interim consolidated accounting period were ¥637 million.」

    Disclosed total R&D expenses of ¥637 million for FY2025-H1.
  4. FY2024Updated the full-year amountAnnual report

    「The number of development personnel in the fiscal year was 94, and ¥1,157 million was spent on research and development.」

    Disclosed 94 development personnel and ¥1,157 million in R&D expenses for the full year. R&D expenses were updated from ¥1,154 million in the previous fiscal year.
  5. FY2024-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥857 million.」

    The company disclosed research and development expenditure of ¥857 million for the cumulative third quarter of FY2024.
  6. FY2024-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥574 million.」

    The company disclosed research and development expenditure of ¥574 million for the cumulative second quarter of FY2024.
  7. FY2024-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥291 million.」

    The company disclosed research and development expenditure of ¥291 million for the cumulative first quarter of FY2024.
  8. FY2023Updated the full-year amountAnnual report

    「The company had 107 development personnel during the current consolidated fiscal year and invested ¥1,154 million in research and development.」

    The company disclosed 107 full-year development personnel and research and development expenditure of ¥1,154 million.
  9. FY2023-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥865 million.」

    The company disclosed research and development expenditure of ¥865 million for the cumulative third quarter of FY2023.
  10. FY2023-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥581 million.」

    The company disclosed research and development expenditure of ¥581 million for the cumulative second quarter of FY2023.
  11. FY2023-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥300 million.」

    The company disclosed research and development expenditure of ¥300 million for the cumulative first quarter of FY2023.
  12. FY2022Updated the full-year amountAnnual report

    「The company had 94 development personnel during the current consolidated fiscal year and invested ¥1,150 million in research and development.」

    The company disclosed 94 full-year development personnel and research and development expenditure of ¥1,150 million.
  13. FY2022-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥880 million.」

    The company disclosed research and development expenditure of ¥880 million for the cumulative third quarter of FY2022.
  14. FY2022-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥581 million.」

    The company disclosed research and development expenditure of ¥581 million for the cumulative second quarter of FY2022.
  15. FY2022-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥290 million.」

    The company disclosed research and development expenditure of ¥290 million for the cumulative first quarter of FY2022.
  16. FY2021Updated the full-year amountAnnual report

    「The company had 94 development personnel during the current consolidated fiscal year and invested ¥1,134 million in research and development.」

    The company disclosed 94 full-year development personnel and research and development expenditure of ¥1,134 million. The amount was updated from the previous fiscal year’s research and development expenditure of ¥1,110 million.
  17. FY2021-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥861 million.」

    The company disclosed research and development expenditure of ¥861 million for the cumulative third quarter of FY2021.
  18. FY2021-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥580 million.」

    The company disclosed research and development expenditure of ¥580 million for the cumulative second quarter of FY2021.
  19. FY2021-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥238 million.」

    The company disclosed research and development expenditure of ¥238 million for the cumulative first quarter of FY2021.
  20. FY2020Updated the full-year amountAnnual report

    「The company had 94 development personnel during the current consolidated fiscal year and invested ¥1,110 million in research and development.」

    The company disclosed 94 full-year development personnel and research and development expenditure of ¥1,110 million.
  21. FY2020-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥823 million.」

    The company disclosed research and development expenditure of ¥823 million for the cumulative third quarter of FY2020.
  22. FY2020-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥544 million.」

    The company disclosed research and development expenditure of ¥544 million for the cumulative second quarter of FY2020.
  23. FY2020-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥238 million.」

    The company disclosed research and development expenditure of ¥238 million for the cumulative first quarter of FY2020.
  24. FY2019-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥830 million.」

    The company disclosed research and development expenditure of ¥830 million for the cumulative third quarter of FY2019.
  25. FY2019-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥526 million.」

    The company disclosed research and development expenditure of ¥526 million for the cumulative second quarter of FY2019.
  26. FY2019-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥267 million.」

    The company disclosed research and development expenditure of ¥267 million for the cumulative first quarter of FY2019.
  27. FY2018Updated the full-year amountAnnual report

    「The company had 95 development personnel during the current consolidated fiscal year and invested ¥1,014 million in research and development.」

    The company disclosed 95 full-year development personnel and research and development expenditure of ¥1,014 million. The amount was updated from the previous fiscal year’s research and development expenditure of ¥1,207 million.
  28. FY2018-Q3Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥748 million.」

    The company disclosed research and development expenditure of ¥748 million for the cumulative third quarter of FY2018.
  29. FY2018-Q2Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative second quarter of the current consolidated fiscal year was ¥539 million.」

    The company disclosed research and development expenditure of ¥539 million for the cumulative second quarter of FY2018.
  30. FY2018-Q1Updated the quarterly amountAnnual report

    「The total research and development expenditure incurred by our group during the cumulative first quarter of the current consolidated fiscal year was ¥298 million.」

    The company disclosed research and development expenditure of ¥298 million for the cumulative first quarter of FY2018.
  31. FY2017Updated the full-year amountAnnual report

    「The company had 115 development personnel during the current consolidated fiscal year and invested ¥1,207 million in research and development.」

    The company disclosed full-year research and development expenditure of ¥1,207 million.
  32. FY2017-Q3First statedAnnual report

    「The total research and development expenditure incurred by our group during the cumulative third quarter of the current consolidated fiscal year was ¥905 million.」

    The company disclosed total research and development expenditure of ¥905 million for the cumulative third quarter of the current consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Teac's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.